To determine the correlation between IL-6R expression and the gemcitabine response in CCA patients, we performed IHC staining in CCA samples in which tumor tissues were treated with gemcitabine by histoculture drug response assay (HDRA) as previously described (Suksawat et al., 2019). This evidence concerns the gene IL6R and neoplasm.